Regeneron Pharmaceuticals REGN
NASDAQ REGN
$831.29 -12.18 (-1.44%)
As of: Sep 4, 2026 · 2:54 PM EDT

Regeneron Pharmaceuticals (REGN) Dividend Coverage Ratio Growth (1y) (2026)

Analysis

Regeneron Pharmaceuticals (REGN) Dividend Coverage Ratio Growth (1y) (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Cover Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -10.85%
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.92 Bn 34.83 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.33 Bn 32.03 Bn 992.69 Mn -
8 Royalty Pharma 28.36 Bn 27.52 Bn - -1.84%
9 Insmed 27.43 Bn 26.27 Bn 358.27 Mn -
10 Incyte 25.63 Bn 21.09 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.85%
Mar 31, 2026 -13.76%